U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You
  FAQs Site Map About MedelinePlus Contact Us
español
Reuters Health Information Logo

Multiple sclerosis may lead to lower cancer risk

Printer-friendly version E-mail this page to a friend

Reuters Health

Monday, March 30, 2009

LONDON (Reuters) - People with multiple sclerosis may have a lower risk of cancer, possibly because of lifestyle changes they make after they are diagnosed with the neurological condition, researchers said on Monday.

An analysis of the medical records of more than 20,000 people with multiple sclerosis showed that patients had a 10 percent lower risk of cancer over 35 years than people without MS.

"We speculate that the lower risk for cancer among people with MS could be a result of lifestyle changes or treatment following diagnosis," Shahram Bahmanyar of Sweden's Karolinksa Institute, who led the study, said in a statement.

The effect was more pronounced among women, who are more prone to MS, an incurable condition that affects more than 1 million people worldwide.

MS can cause mild symptoms in some people and permanent disability in others. Symptoms may include numbness or weakness in one or more limbs, partial or complete loss of vision, tingling or pain, electric-shock sensation with certain head movements, tremors and an unsteady gait.

Bahmanyar and colleagues, who published their findings in the journal Neurology, compared the records of the men and women with MS with those of more than 200,000 people without the disease over 35 years.

They also analyzed records of parents of people with MS to see if there was a genetic link, but found no overall increased or decreased risk among parents.

The findings suggested MS patients are more likely to be diagnosed with certain cancers such as brain or bladder tumors, which the researchers said may happen because these patients are being examined more often than other people.

"The increase in brain tumor diagnoses may be due to brain inflammation, but this finding may not reflect a real increase in cancer risk, as there is some evidence that more frequent neurological investigations in these patients mean that brain tumors are more likely to be found sooner," Bahmanyar said.

(Reporting by Michael Kahn, editing by Maggie Fox, Tim Pearce)


Reuters Health

© 2009 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies. For additional information on other Reuters media services please visit http://about.reuters.com/media/.

Related News:
More News on this Date

Related MedlinePlus Pages: